Jane Street Group, LLC Rvl Pharmaceuticals PLC Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.17 $3,741 - $7,817	-6,682 Reduced 37.57%	11,103 $6,000
Q1 2023 May 15, 2023	BUY	$1.02 - $1.39 $18,140 - $24,721	17,785 New	17,785 $20,000
Q3 2021 Nov 16, 2021	SELL	$2.79 - $4.19 $97,728 - $146,767	-35,028 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.8 - $3.78 $98,078 - $132,405	35,028 New	35,028 $105,000
Q1 2021 May 18, 2021	SELL	$3.26 - $4.84 $33,069 - $49,096	-10,144 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$4.12 - $6.29 $41,793 - $63,805	10,144 New	10,144 $42,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.